Form 4: OptimizeRx Corp Insider Sells Shares for Tax Withholding
Statement of Changes in Beneficial Ownership
OptimizeRx Corp CEO Stephen L. Silvestro disposed of 5,219 shares of common stock to cover tax obligations upon the vesting of restricted stock units.
Summary
- Stephen L. Silvestro, Chief Executive Officer of OptimizeRx Corp, reported a disposition of 5,219 shares of common stock on May 15, 2026.
- The shares were withheld by the company to satisfy the reporting person's tax withholding obligations related to the vesting of restricted stock units.
- This transaction is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934.
- Following this transaction, Silvestro beneficially owns 185,288 shares of common stock directly.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral event. The disposition of shares is for tax withholding purposes upon vesting of RSUs, a standard administrative process, rather than a sale driven by negative sentiment or a lack of confidence in the company's future.
Negatives
- Insider selling, even for tax purposes, can sometimes be perceived negatively by the market.
Future Outlook
No specific future outlook or guidance is provided in this filing.
Management Comments
- "These shares were withheld by the Issuer upon the vesting of restricted stock units to satisfy the Reporting Person's tax withholding obligations."
- "Such withholding is treated as a disposition of securities under Section 16 of the Securities Exchange Act of 1934, as amended."
- "The filing of this Statement shall not be construed as an admission (a) that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or (b) that this Statement is legally required to be filed by such person."
Industry Context
StockSavvy.ai notes that insider transactions, particularly those involving tax withholding upon vesting of equity awards, are common within the technology and healthcare sectors where OptimizeRx Corp operates. These events are typically administrative rather than indicative of a change in the executive's confidence in the company's prospects.
Stakeholder Impact
- Shareholders: The disposition of shares by a key executive for tax purposes is a routine event and is not expected to have a significant direct impact on the share price or overall shareholder value, though it reduces the executive's direct holdings.
Key Dates
| Date | Description |
|---|---|
| 05/15/2026 | Transaction Date (Disposition of shares) |
| 05/18/2026 | Date of Signature on the filing |
Keywords
OptimizeRx Corp, OPRX, Form 4, Insider Transaction, Stock Disposition, Tax Withholding, Restricted Stock Units, Stephen L. Silvestro, CEO
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.